Towards the understanding of microRNA and environmental factor interactions and their relationships to human diseases

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Qiu, Chengxiang ^a   Chen, Geng ^a   Cui, Qinghua ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; DISEASES; GENETICS; HUMAN;

DISEASE; HUMANS; MICRORNAS;

EID: 84859748673     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00318     Document Type: Article

References (28)

1. Barabasi, A. L., Gulbahce, N. & Loscalzo, J. Network medicine: a network-based approach to human disease. Nat Rev Genet 12 (1), 56 (2011).
2. Yildirim, M. A. et al. Drug-target network. Nat Biotechnol 25 (10), 1119 (2007).
3. Campillos, M. et al. Drug target identification using side-effect similarity. Science 321 (5886), 263 (2008).
4. Dudley, J. T., Deshpande, T. & Butte, A. J. Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform 12 (4), 303 (2011).
5. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2), 281 (2004).
6. Esquela-Kerscher, A. & Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6 (4), 259 (2006).
7. Lu, M. et al. An analysis of human microRNA and disease associations. PLoS ONE 3(10)e3420. doi:10. 1371/journal. pone. 0003420 (2008).
8. Lima, R. T. et al. MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 47 (2), 163 (2011).
9. Lin, Z. & Flemington, E. K. miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett 305 (2), 186 (2011).
10. Ladeiro, Y. et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47 (6), 1955 (2008).
11. Izzotti, A. et al. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 31 (5), 894 (2010).
12. Gidron, Y. De Zwaan, M., Quint, K. & Ocker, M. Influence of stress and healthbehaviour on miRNA expression. Mol Med Report 3 (3), 455 (2010).
13. Alisi, A. et al. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest 91 (2), 283 (2011).
14. Niemoeller, O. M. et al. MicroRNA expression profiles in human cancer cells after ionizing radiation. Radiat Oncol 6, 29 (2011).
15. Yang, Q. et al. miREnvironment Database: providing a bridge for microRNAs, environmental factors, and phenotypes. Bioinformatics 27(23), 3329 (2011).
16. Poy, M. N. et al. miR-375 maintains normal pancreatic alpha-and beta-cell mass. Proc Natl Acad Sci USA 106 (14), 5813 (2009).
17. Questionable methods of cancer management: hydrogen peroxide and other 'hyperoxygenation' therapies. CA Cancer J Clin 43 (1), 47 (1993).
18. Veal, E. A., Day, A. M. & Morgan, B. A. Hydrogen peroxide sensing and signaling. Mol Cell 26 (1), 1 (2007).
19. Lopez-Lazaro, M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 252 (1), 1 (2007).
20. Wang, D. et al. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One 5 (9) (2010).
21. Cao, Y. X., Dai, C. W. & Zhang, G. S. [Screening for drug resistance related microRNAs in K562 and K562/A02 cell lines.[. Zhonghua Xue Ye Xue Za Zhi 31 (6), 361 (2010).
22. Wang, X. C. et al. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 72 (1), 92 (2011).
23. Li, Y. et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69 (16), 6704 (2009).
24. Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313 (5795), 1929 (2006).
25. Sirota, M. et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 3 (96), 96ra77 (2011).
26. Smikle, M. F. et al. Autoantibodies, human T lymphotropic virus type 1 and type 1 diabetes mellitus in Jamaicans. West Indian Med J 51 (3), 153 (2002).
27. Liang, Y., Ridzon, D. Wong, L. & Chen, C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8, 166 (2007).
28. Lu, M. et al. TAM: amethod for enrichment and depletion analysis of amicroRNA category in a list of microRNAs. BMC Bioinformatics 11, 419 (2010).